Lawrence Blonde

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

John B. Buse, Julio Rosenstock, Giorgio Sesti et al. · The Lancet · 2009 · 1.5K citations

Open-label Trial, Diabetes Management, Medicine +6

Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY

Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay et al. · Endocrine Practice · 2016 · 874 citations

Metabolic Syndrome, Diabetes Management, Comprehensive Type 2 +5

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Bernard Zinman, John Gerich, John B. Buse et al. · Diabetes Care · 2009 · 834 citations · Full text

American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary

Yehuda Handelsman, Zachary T. Bloomgarden, George Grunberger et al. · Endocrine Practice · 2015 · 629 citations · Full text

Family Medicine, Diabetes Management, Health Policy +9

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

Alan J. Garber, Yehuda Handelsman, George Grunberger et al. · Endocrine Practice · 2020 · 592 citations · Full text

Diabetes Management, Comprehensive Type 2, Health Policy +4